Cortex Pharmaceutic Stock Gross Profit
| PHXDelisted Stock | USD 4.35 0.00 0.00% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess CORTEX PHARMACEUTIC's long-term financial health and intrinsic value.
CORTEX |
CORTEX PHARMACEUTIC Company Gross Profit Analysis
CORTEX PHARMACEUTIC's Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Current CORTEX PHARMACEUTIC Gross Profit | 30.11 M |
Most of CORTEX PHARMACEUTIC's fundamental indicators, such as Gross Profit, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, CORTEX PHARMACEUTIC is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
CompetitionAccording to the company disclosure, CORTEX PHARMACEUTIC reported 30.11 M of gross profit. This is 99.97% lower than that of the Oil, Gas & Consumable Fuels sector and 99.07% lower than that of the Energy industry. The gross profit for all Germany stocks is 99.89% higher than that of the company.
CORTEX Gross Profit Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses CORTEX PHARMACEUTIC's direct or indirect competition against its Gross Profit to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of CORTEX PHARMACEUTIC could also be used in its relative valuation, which is a method of valuing CORTEX PHARMACEUTIC by comparing valuation metrics of similar companies.CORTEX PHARMACEUTIC is currently under evaluation in gross profit category among its peers.
CORTEX Fundamentals
| Return On Equity | 0.0555 | |||
| Return On Asset | 0.0185 | |||
| Profit Margin | 0.19 % | |||
| Operating Margin | (0.04) % | |||
| Current Valuation | 182.81 M | |||
| Shares Outstanding | 37.92 M | |||
| Shares Owned By Insiders | 15.10 % | |||
| Shares Owned By Institutions | 69.39 % | |||
| Number Of Shares Shorted | 123.3 K | |||
| Price To Earning | 21.21 X | |||
| Price To Book | 1.31 X | |||
| Price To Sales | 4.58 X | |||
| Revenue | 34.27 M | |||
| Gross Profit | 30.11 M | |||
| EBITDA | 15.32 M | |||
| Net Income | 2.32 M | |||
| Cash And Equivalents | 3.4 M | |||
| Cash Per Share | 0.12 X | |||
| Total Debt | 30.2 M | |||
| Debt To Equity | 0.30 % | |||
| Current Ratio | 1.49 X | |||
| Book Value Per Share | 3.44 X | |||
| Cash Flow From Operations | 18.08 M | |||
| Short Ratio | 0.13 X | |||
| Earnings Per Share | 0.19 X | |||
| Target Price | 4.35 | |||
| Number Of Employees | 18 | |||
| Beta | 0.064 | |||
| Market Capitalization | 164.96 M | |||
| Total Asset | 163.92 M | |||
| Retained Earnings | 77.07 M | |||
| Working Capital | 6.32 M | |||
| Current Asset | 6.57 M | |||
| Current Liabilities | 4.47 M | |||
| Annual Yield | 0.04 % | |||
| Five Year Return | 1.88 % | |||
| Net Asset | 163.92 M | |||
| Last Dividend Paid | 0.15 |
About CORTEX PHARMACEUTIC Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze CORTEX PHARMACEUTIC's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CORTEX PHARMACEUTIC using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CORTEX PHARMACEUTIC based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in CORTEX Stock
If you are still planning to invest in CORTEX PHARMACEUTIC check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the CORTEX PHARMACEUTIC's history and understand the potential risks before investing.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |